The chemical class known as SMG7 Activators encompasses a range of compounds that have been identified to enhance the expression or activity of the human SMG7 protein. SMG7, a critical component of the nonsense-mediated mRNA decay (NMD) pathway, ensures the fidelity of gene expression by targeting erroneous mRNA transcripts for degradation. Activators in this class may operate through various molecular mechanisms, including the alteration of transcriptional regulation, modification of mRNA stability, or extension of the protein's lifespan within the cell. These chemicals are integral tools for researchers aiming to dissect the pathways that control the NMD process and to understand the broader implications of SMG7 function within cellular biology. The chemical activators can be grouped based on their target interaction within the cell; some may influence the epigenetic markers that regulate DNA transcription, while others might interact with proteostatic mechanisms to inhibit the degradation of the SMG7 protein.
Within the realm of molecular biology and genetics, SMG7 Activators are valuable for their ability to modulate the expression of SMG7, providing a window into the cellular machinery that governs protein synthesis and degradation. By artificially upregulating SMG7, scientists can observe the ramifications of altered NMD activity and glean insights into the protein's role in maintaining genomic stability and cellular homeostasis. These activators are diverse, including but not limited to, compounds that affect the cell's transcriptional machinery, small molecules that stabilize mRNA, and agents that prevent protein breakdown. Research involving these activators often focuses on the fundamental understanding of gene regulation and the complex interplay between different cellular pathways. By studying the effects of these activators on SMG7 expression, researchers can further unravel the intricate network of cellular surveillance that protects against the accumulation of potentially deleterious proteins resulting from premature stop codons in mRNA sequences.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which may enhance transcription of genes including SMG7. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Inhibits DNA methyltransferase, potentially leading to demethylation and activation of SMG7 gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, possibly causing chromatin remodeling and upregulation of SMG7. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Binds to retinoic acid receptors, which may regulate SMG7 gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Modulates GSK-3β activity, which could affect SMG7 expression through Wnt signaling pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Activates the vitamin D receptor, potentially affecting SMG7 gene transcription in a cell-type-specific manner. | ||||||